A cross-sectional study was conducted on the performance of tuberculin skin test (TST) and QuantiFERON®-TB Gold In-tube test (QFT-IT) for detecting latent tuberculosis infection among Thai healthcare workers (HCWs). Each HCW underwent simultaneous TST and QFT-IT during the annual health screening. Among 260 HCWs enrolled, the median age was 30 (range 19-60 years), 92% were female, 64% were nurses and nurse assistants, 78% were BCGvaccinated, and 37% had previous TST. Correlation between TST reaction size and level of interferon-γ (IFN-γ) was weak (r = 0.29; P<0.001). Thirty-eight percent and 20% of HCWs had reactive TST and positive QFT-IT, respectively. Using QFT-IT positivity as standard for latent tuberculosis diagnosis, the cut-off for TST reactivity with the best performance was ≥ 13 mm with sensitivity, specificity, false positivity and false negativity of 71%, 70%, 30% and 29%, respectively (area under the curve 0.73; P<0.001). Independent factor associated with false reactive TST was previous TST (adjusted odds ratio 1.83; P=0.04). Our findings suggest that QFT-IT may be a preferred test among HCWs with previous TST. In settings where QFT-IT is not available, appropriate cut-offs for TST reactivity should be evaluated for use among HCWs.
TST has been long used as a diagnostic tool for LTBI given its ready availability and low cost.
However, limitations of TST include false reactivity from the BCG vaccine and non-tuberculous mycobacterial (NTM) infection, administrative and interpretative errors, and the requirement of two clinic visits (8). A blood-based assay, IGRA, that detects interferon level after the in-vitro stimulation of a subject's white blood cells with specific Mycobacterium tuberculosis antigens, has been developed in the past decade (9). The advantages of IGRA over TST are its higher sensitivity and specificity, no cross reaction with prior BCG vaccination or other NTM, single visit testing, and a more objective result (8). Nonetheless, IGRAs are more expensive than TST and are not available in all settings, especially in TB-endemic resource-limited settings.
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Thailand is TB-endemic and has the estimated TB prevalence of 149 cases per 100,000 population (10). The country's national guidelines have not been established for LTBI screening among Thai HCWs given the concern about TST limitations (8). Comparative data on the performance of TST and IGRA in LTBI detection is largely from low TB prevalence settings (8).
Among Asian countries (Table 1) , the overall agreement between TST and IGRA results was poor to fair and depended on the cut-offs for TST reactivity used (11-23). The main factor reported to be associated with poor agreement between the two tests was prior BCG vaccination which resulted in false reactivity of TST (23) . The higher rates of TST reactivity compared to the rates of IGRA positivity in most studies suggest the false reactivity of TST among HCWs.
Using the lower cut-off level [i.e. 10 mm as recommended by CDC for employees of TB highrisk settings (2)] would increase the rate of TST false reactivity in settings with high rates of BCG vaccination while using too high cut-off level (i.e. 15 or 18 mm) would falsely increase the rate of TST non-reactivity and may not be appropriate in the settings with low rate of BCG vaccination and/or HCWs with waning immunity after long duration of the last BCG vaccination.
The appropriate cut-off for TST reactivity among HCWs in Thailand is unknown and factors associated with discordant results between TST and IGRA have rarely been described. We conducted a study to evaluate characteristics of HCWs associated with LTBI and compare the performance of TST and IGRA in diagnosing LTBI among Thai HCWs and determine factors associated with discordant results between these two tests.
METHODS

A c c e p t e d
M a n u s c r i p t The TSTs were performed and read dually and blindly by two nurses who were trained and had experience on TST procedure. We searched for the best cut-off of skin induration size to define TST reactivity using the results of IGRA as reference standard in this study.
Statistical analysis.
A sample size of 170 subjects was estimated to detect a 12% difference between IGRA and TST in rates of LTBI diagnosis, with a significance level at 0.05 and 80%
power. This estimate was based on the LTBI detection rate of 14.3% via IGRA and 2.3% via TST reported in a meta-analysis (26) . All analyses were performed using SPSS, version 15 
RESULTS
Baseline characteristics of study patients
There were 285 HCWs screened during the study period. Eighteen (6%) who declined participation and 7 (3%) who had history of TB were excluded ( (Table 2) .
Correlation and agreement between variables
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Latent tuberculosis infection test results
When using the cut-off of ≥ 13 mm for TST reactivity, there were 114 HCWs identified with IU/ml), with no significant difference in the median IFN-γ when results were stratified by TST reactive (0.71 IU/ml) and non-reactive subjects (0.71 IU/ml).
In multivariable logistic regression analyses ( between the two tests, independent factors associated with TST reactivity and negative QFT-IT was previous TST (aOR 1.83; 95% CI 1.03-3.27; P=0.04) while no factor was identified to be associated with non-reactive TST and positive QFT-IT.
Performance of TST compared to QFT-IT
When using QFT-IT result as the reference standard for LTBI diagnosis and the cut-off of ≥ 13 mm for TST reactivity, the TST sensitivity, specificity, PPV and NPV were 71%, 70%, 37% and 91%, respectively (Table 4 ). The false positive and false negative rates of TST were 30% and 29%, respectively. The ROC curve analysis of TST indicated the area under the curve (AUC) of 0.73 (95% CI 0.66-0.81; P<0.001) and indicated the best performance of TST when using the cut-off of ≥ 13 mm ( Figure 2C ). The other cut-offs for TST reactivity had poorer performance than this cut-off as shown in Table 4 .
DISCUSSION
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Our study demonstrated the fair agreement between TST and QFT-IT results depending on the cut-off for TST reactivity used, consistent with the results from other studies conducted in Asian countries (Table 1 ). In our setting with the high rate of BCG vaccination (78%) among HCWs and the median duration from the latest BCG vaccination was 30 years, the TST reaction cut-off of ≥13 mm had the best agreement with IGRA results while other studies in Table 1 reported the best agreement using different cut-off levels from ≥10 mm to ≥18 mm. These findings suggest that the appropriate cut-off for TST reactivity among HCWs needs to be studied in each setting and be determined based on the influence of BCG vaccination.
We identified prior TST as an independent factor associated with false reactivity of TST consistent with reports from the previous studies (27, 28) . However, we did not find the significant correlation between the TST reaction size and the duration since the last performed TST. These findings may be explained by the booster phenomenon after receiving a repeated TST as observed in the two-step TST procedure (29) and/or the persistent immunological responses to tuberculin overtime. These findings also imply that HCWs who underwent prior TST may benefit from IGRA testing. However, if IGRA is not available, repeated or serial TST among previous TST-nonreactive HCWs may be performed at the intervals based on the risk classification of the facility (3) but should not be performed more frequently than every year.
The TST results should be interpreted with caution taking into account for the potential false reactivity, which may lead to unnecessary INH chemoprophylaxis and subsequent risk for adverse drug reactions, especially liver toxicity. IGRA and how to better use TST if IGRA is not available. Third, since most of the HCWs in our study were nurses and nurse assistants in early adulthood with median working duration of 5 years and most had history of TB contact, the results may not be generalizable to other settings with differences in HCWs' characteristics. Lastly, there might be recall biases in regards to history of BCG vaccination and TB contact.
In conclusion, IGRA may be a preferred LTBI diagnostic test for HCWs in TB-endemic regions given its higher sensitivity and results independent of BCG vaccination effect. In settings where IGRA is not available, TST remains the LTBI diagnostic test of choice for HCWs. However, the cut-off for reactivity needs to be adjusted according to results from locally-conducted studies. In settings where IGRA is available but the cost of the screening tests is of concern, our findings 
FIGURE 2 LEGEND
Correlations between tuberculin skin test (TST) reaction size and interferon-gamma level (A)
The kappa coefficient for agreement between results of TST and QuantiFERON®-TB Gold Intube Test (QFT-IT) at different reaction size cut-offs for TST reactivity (B)
Receiver operating characteristics curve analysis of TST using QFT-IT results as standard for diagnosis of latent tuberculosis infection (C).
a TST reaction size of at least equal or larger than each cut-off was considered TST reactivity.
AUC = area under the curve.
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